Personal Injury & Mass Tort Funding
Companies providing pre-settlement advances to individual plaintiffs in personal injury, medical malpractice, and mass tort cases pending resolution of their legal claims.
Market snapshot
These figures describe Litigation Finance (3.5.5), the segment that Personal Injury & Mass Tort Funding sits within — not Personal Injury & Mass Tort Funding on its own.
No discrete Census NAICS code — litigation finance sits within financial-investment and funds classifications (523/525), so the segment is not separately sized by the Census Bureau.
Business model & economics
Revenue model
Share of legal-claim proceeds on non-recourse funding
Key economics
- Recurring revenue
- Low
- EBITDA margin
- High but idiosyncratic, outcome-dependent
- Capex intensity
- Low
case- and portfolio-outcome driven
Characteristics
- Alternative-asset class with uncorrelated returns.
- Funds legal claims and law-firm portfolios non-recourse.
- Emerging, increasingly institutionalized market.
M&A deal context
Who’s acquiring
- Litigation-finance specialists
- Alternative-asset managers
- Institutional capital allocators
What’s driving deals
- Institutionalization of legal-claim funding.
- Demand for uncorrelated alternative returns.
- Growing law-firm and corporate use of third-party capital.
Find Personal Injury & Mass Tort Funding acquisition targets
Search Acquisera’s index for companies classified under Personal Injury & Mass Tort Funding (3.5.5.4) and build a targeted deal pipeline.
Search companies